Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 17
Phase 27

Trial Status

Other7

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT01834066Phase 1/2Unknown
Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.
Duchenne Muscular Dystrophy,Muscular Dystrophy
Principalinvestigator
NCT01876017Phase 1/2Unknown
Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure
Chronic Renal Failure
Principalinvestigator
NCT01883661Phase 1/2Unknown
Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)
Multiple Sclerosis
Principalinvestigator
NCT01908400Phase 1/2Unknown
Safety and Efficacy of BMMNCin Patients With Mental Retardation
Mental Retardation
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT01834066Phase 1/2PrincipalInvestigator

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.

Duchenne Muscular Dystrophy,Muscular Dystrophy
Unknown
NCT01876017Phase 1/2PrincipalInvestigator

Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure

Chronic Renal Failure
Unknown
NCT01877759Phase 1/2PrincipalInvestigator

A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis

Liver Cirrhosis
Unknown
NCT01883661Phase 1/2PrincipalInvestigator

Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

Multiple Sclerosis
Unknown
NCT01908400Phase 1/2PrincipalInvestigator

Safety and Efficacy of BMMNCin Patients With Mental Retardation

Mental Retardation
Unknown
NCT01914913Phase 1/2PrincipalInvestigator

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Retinitis Pigmentosa
Unknown
NCT01958177Phase 1/2PrincipalInvestigator

Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

Cerebellar Ataxia
Unknown

All 7 trials loaded